Abstract:Introduction: Lung cancer is the leading cause of death worldwide. One third of lung adenocarcinomas (LUADs), the most abundant form of lung cancer, harbors activating mutations in KRAS. Since human KRAS-mutant LUAD is correlated to an inflammatory phenotype, we hypothesized that the JAK-STAT pathway plays a crucial role in disease progression. Indeed, preliminary data demonstrated that human KRAS-mutant LUADs are associated with activation of the JAK-STAT signaling pathway, including upregulation of STAT1 expression. Therefore, we aimed to elucidate the tumorigenic functions of STAT1 in KRAS-mutant LUAD. Methods: To analyze the functions of STAT1 in KRAS-driven LUAD, we used C57BL/6 mice, which were genetically engineered in order to develop KRAS-driven autochthonous LUAD deficient for P53. Tumors additionally expressed ovalbumin (OVA) which acts as a neoantigen to induce immune infiltration (KPO mice). In this immunogenic mouse model, STAT1 was deleted in the tumors (KPOS mice) and overall survival was assessed by Kaplan Meier analysis. Tumor burden and infiltration was analyzed in lungs via H&E, IHC, and IF staining 6 weeks after tumor induction. An inflammatory cytokine antibody array was performed with lung fluid and single cell sequencing with cells isolated from lungs at 10 weeks. Results and discussion: Expression of OVA in tumor cells increased infiltration by T cells and prolonged survival suggesting neoantigen presentation in this mouse model. When STAT1 was deleted in OVA expressing tumors the survival was significantly decreased. Further, tumor burden as well as tumor size and grades were increased in KPOS lungs. Interestingly, infiltration of CD4 T cells was diminished upon loss of STAT1 while the percentage of CD8 T cells in tumors did not change suggesting an immunosuppressive tumor microenvironment. Indeed, M2 macrophages were increased in tumors lacking STAT1 and less proliferating immune cells were found indicating immune cell inhibition. This was further supported by the increase of CCL9 in KPOS lungs which might induce macrophage recruitment and further T cell inhibition. Finally, scRNAseq analysis revealed that KPOS lungs were composed of distinct immune cell populations as well as states. Conclusion: This data suggests that loss of STAT1 in tumor cells promotes secretion of CCL9 that drives recruitment of immunosuppressive macrophages to the tumor microenvironment. As a result, T helper cells are excluded from tumors and cytotoxic T cells are inhibited or exhausted. Further experiments will delineate the immune cell states and the mechanisms leading to this interesting phenotype. Citation Format: Christoph Trenk, Maša Bereš, Katalin Deszo, Jaqueline Horvath, Monika Homolya, Andreea Corina Luca, Robert Eferl, Herwig Peter Moll, Emilio Casanova. Loss of STAT1 promotes an immunosuppressive tumor microenvironment in KRAS-driven lung adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6862.

A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes

NFATc2 promotes lactate and M2 macrophage polarization through USP17 in lung adenocarcinoma

NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis

The Dual Role of the NFATc2/galectin-9 Axis in Modulating Tumor-Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma

Abstract 105: Understanding the role of β2-adrenergic receptor signaling on type II innate lymphoid cells in cancer

Increased immunosuppressive function of CD4(+)CD25(+)Foxp3(+)GITR+ T regulatory cells from NFATc2((-/-)) mice controls allergen-induced experimental asthma

The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis

Neutrophils Recruited by NKX2-1 Suppression via Activation of CXCLs/CXCR2 Axis Promote Lung Adenocarcinoma Progression

The Interplay Between ATF2 and NEAT1 Contributes to Lung Adenocarcinoma Progression.

Abstract 6862: Loss of STAT1 promotes an immunosuppressive tumor microenvironment in KRAS-driven lung adenocarcinoma

Abstract #5347: the Lung Tumor Suppressor GPRC5A Inhibits Activation of NF-\#954;B in Human Non-Small Cell Lung Adenocarcinoma Cells

Knockout of the Tumor Suppressor Gene Gprc5a in Mice Leads to NF-κB Activation in Airway Epithelium and Promotes Lung Inflammation and Tumorigenesis

Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells

Chronic NF-κB Activation Links COPD and Lung Cancer Through Generation of an Immunosuppressive Microenvironment in the Lungs.

Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis

Roles of naïve CD4+ T cells and their differentiated subtypes in lung adenocarcinoma and underlying potential regulatory pathways

Abstract 5884: Targeting T regulatory cells to intercept progression from preinvasive to invasive lung adenocarcinoma using a novel KRAS-driven murine model

IKK-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines

Overexpression of Activating Transcription Factor-2 (ATF-2) Activates Wnt/Ca2+ Signaling Pathways and Promotes Proliferation and Invasion in Non-Small-Cell Lung Cancer

BATF2 inhibits PD-L1 expression and regulates CD8+T cells infiltration in non-small cell lung cancer

Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation